Mode
Text Size
Log in / Sign up

Report describes colorectal cancer screening prevalence by age, demographics, and state in the USColorectal cancer is the second deadliest cancer. How many people are getting screened?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note descriptive report on US CRC screening prevalence by demographics and state.

A descriptive report provides information on colorectal cancer screening test use within the United States population. The report's primary outcome is current colorectal cancer screening prevalence. It notes that colorectal cancer is the second leading cause of cancer death in the US.

The main findings describe current colorectal cancer screening prevalence by age, various demographic factors, and by state. No specific intervention, comparator, sample size, or follow-up duration is reported. The report does not provide effect sizes, absolute numbers, p-values, or confidence intervals for the described prevalence patterns.

No safety, tolerability, or adverse event data are reported, as this is not an interventional study. Key methodological details such as study phase, funding sources, and potential conflicts of interest are not reported. The report's limitations are not explicitly stated.

This report offers a descriptive, cross-sectional look at screening patterns. It does not establish causality or test the effectiveness of any specific screening intervention. The findings are relevant for understanding the current landscape of colorectal cancer screening utilization across different populations and geographies in the US.

Colorectal cancer is a serious threat, ranking as the second leading cause of cancer death in the United States. That's the stark reality behind a new report that takes a detailed look at how many Americans are getting screened for this disease. Screening can catch cancer early, when it's most treatable, which makes understanding who is and isn't getting tested a crucial public health question.

The report describes the current prevalence of colorectal cancer screening across the country. It doesn't give a single national percentage, but instead breaks the picture down by a person's age, various demographic factors, and by individual state. This kind of mapping helps identify where screening efforts might be falling short for specific groups of people or in certain parts of the country.

It's important to understand what this report is and isn't. This is a descriptive snapshot of the current situation. It tells us 'what' the screening levels are in different places and among different people, but it doesn't explain 'why' those levels exist or what might be causing any gaps. The report also doesn't track changes over time or predict future trends. It simply lays out the landscape as it stands, providing a baseline for understanding a critical part of cancer prevention.

What this means for you:
A new report maps colorectal cancer screening rates across the U.S., showing where prevention efforts stand.

Study Details

EvidenceLevel 5
PublishedMar 2020
View Original Abstract ↓
Of cancers that affect both men and women, colorectal cancer (CRC) is the second leading cause of cancer death in the United States. This report describes current CRC screening prevalence by age, various demographic factors, and state.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.